Aptevo Therapeutics Reports 2Q23 Financial Results and Provides a Business ...
Aptevo Therapeutics Reports 2Q23 Financial Results and Provides a Business ...
Source: pr-inside.com
Stay updated with breaking news from Benchmark Composite References. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Aptevo Therapeutics Reports 2Q23 Financial Results and Provides a Business ...
New Data Adds to Growing Body of Clinical Evidence in Support of APVO436 Clinical Potential SEATTLE, WA - July 18, 2023 - Aptevo Therapeutics Inc. , a clinical-stage...
Company Achieves Multiple Clinical and Scientific Milestones in 2022, Poised for APVO436 Phase 2 in AML 2H23, ALG.APV-527 dosing initiated 1Q23 for Solid TumorsSEATTLE, WA / ACCESSWIRE / March 30, 2023